Tibet Cheezheng Tibetan Medicine Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Tibet Qizheng Tibetan Medicine Co., Ltd. (referred to as Qizheng Tibetan Medicine) is a leading domestic Tibetan medicine enterprise, mainly engaged in the research and development, production, and sales of new Tibetan medicines. It currently has 21 wholly-owned and controlled subsidiaries such as GMP Pharmaceutical Factory and GSP Marketing Company, with 2869 employees, 25 exclusive varieties, and 141 drug approval numbers. Its products cover the skeletal muscle system, nervous system, digestive system, cardiovascular and cerebrovascular system, respiratory system, urinary system, gynecology, dermatology Pediatrics and other fields. Among them, the external painkillers series represented by Qizheng Pain Eliminating Plaster have been selling well in China for many years and have been sold overseas, with high clinical efficacy rates. Its sales have been among the top in the Chinese external painkillers market for many consecutive years. Qizheng Tibetan Medicine settled in Linzhi, Tibet in 1995, with the responsibility of modern inheritance of Tibetan medicine for thousands of years. Through cultural inheritance and technological innovation, it drives the innovation and upgrading of the traditional Tibetan medicine industry. The company has been recognized as one of the first batch of national innovative enterprises, national high-tech enterprises, national technological innovation demonstration enterprises, key high-tech enterprises of the National Torch Plan, and national enterprise technology centers. It has two national and local joint laboratories, and has successively implemented key projects of the National "Eleventh Five Year Plan" Science and Technology Support Plan and undertaken major scientific and technological projects of the National "Twelfth Five Year Plan" and "Thirteenth Five Year Plan". In more than 20 years of business practice, the company adheres to the core values of "being kind, benefiting others, and doing business", spontaneously and consciously practices corporate social responsibility, always maintaining motivation and heartfelt kindness, and voluntarily maintaining the coexistence and mutual prosperity of nature and social ecology, forming a unique sustainable development system. By the end of 2021, the company has invested a total of 140.8 million yuan in medical care, education, rural revitalization, and donations for the prevention and control of the "COVID-19" epidemic in Tibet and the west. Since its listing, the company has always focused on its main business and maintained steady and sustained growth in performance. In 2021, the company achieved a total operating revenue of 1.77 billion yuan, an increase of 19.22% compared to the same period last year; The net profit attributable to shareholders of the listed company was 716 million, an increase of 77.21% compared to the same period last year. |
| Headquarter | Nyingchi |
| Establish Date | 10/9/2007 |
| Listed Code | 002287.SZ |
| Listed Date | 8/28/2009 |
| Chairman | Lei Jufang. |
| CEO | Liu Kailie. |
| Website | www.cheezheng.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
